Latest Articles

Publication Date
Magnetic Resonance Imaging in Pelvic Endometriosis: Imaging Characteristics and Anatomical Distribution at a Tertiary Care Study.

Endometriosis is a chronic gynecological disorder, characterized by the presence of functional endometrial glands and stroma outside the uterine cavity. It commonly presents with pelvic pain and infertility and may …

Published: June 8, 2026, midnight
Mali Barbi: ASCO 2026 Endometrial Cancer Recap Highlights Potential Curative Signal in dMMR Subtype - Oncodaily

Mali Barbi: ASCO 2026 Endometrial Cancer Recap Highlights Potential Curative Signal in dMMR Subtype Oncodaily

Published: June 7, 2026, 6:12 a.m.
Initial Results of FAPI PET/MRI to Assess the Extent of Endometriosis.

Endometriosis is a common gynecologic disorder often associated with chronic pelvic pain, infertility, and reduced quality of life. Conventional imaging modalities, such as transvaginal ultrasound and MRI, may underestimate the …

Published: June 4, 2026, midnight
UCA1 facilitates endometriosis progression through EIF4A3-mediated stabilization of E2F1 mRNA and enhanced glycolysis.

Long non-coding RNA Urothelial carcinoma-associated 1 (UCA1) is a pivotal regulator in the progression of endometriosis (EMs), yet its mechanistic role remains elusive. This study identified UCA1 as a factor …

Published: June 2, 2026, midnight
Puxitatug Samrotecan Elicits High Response Rate in Select Endometrial Cancers - OncLive

Puxitatug Samrotecan Elicits High Response Rate in Select Endometrial Cancers OncLive

Published: May 30, 2026, 9:59 p.m.
Long-Term RUBY Data Show Potential for Curative Intent With Dostarlimab Combo Shows Durable Disease Control in dMMR/MSI-H Endometrial Cancer - OncLive

Long-Term RUBY Data Show Potential for Curative Intent With Dostarlimab Combo Shows Durable Disease Control in dMMR/MSI-H Endometrial Cancer OncLive

Published: May 30, 2026, 12:24 a.m.
Dostarlimab Plus Chemotherapy Yields Curative Potential in dMMR/MSI-H Endometrial Cancer - CancerNetwork

Dostarlimab Plus Chemotherapy Yields Curative Potential in dMMR/MSI-H Endometrial Cancer CancerNetwork

Published: May 29, 2026, 10:40 p.m.
Dostarlimab/Chemo Shows Curative Potential in dMMR/MSI-H Advanced Endometrial Cancer - Targeted Oncology

Dostarlimab/Chemo Shows Curative Potential in dMMR/MSI-H Advanced Endometrial Cancer Targeted Oncology

Published: May 29, 2026, 10:11 p.m.
Aberrant mRNA Splicing Fuels Endometriotic Cell Growth - Bioengineer.org

Aberrant mRNA Splicing Fuels Endometriotic Cell Growth Bioengineer.org

Published: May 29, 2026, 7:56 p.m.
Correction: Misregulated alternative splicing in endometriosis: a role for aberrant mRNA variants in endometriotic cell growth.

Published: May 29, 2026, midnight
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!